Condition: IgA Vasculitis · Gastrointestinal Involvement · Sponsor: Bursa City Hospital
This prospective observational study aims to evaluate plasma intestinal fatty acid-binding protein (I-FABP) levels in children with IgA vasculitis and investigate their association with gastrointestinal involvement. Blood samples will be collected at diagnosis and during follow-up 2-4 weeks later. The study will assess the potential value of plasma I-FABP as a biomarker for gastrointestinal involvement in pediatric IgA vasculitis.
This description comes directly from the study's public registry record.
Nur Şeyma Zengin, MD · +90 5064767328 · nszengin37@hotmail.com
Tuba Kurt, MD, Associate Professor · +90 553 064 1000 · drtubakurt@hotmail.com
Always discuss trial participation with your own doctor first.
| Bursa City Hospital | Bursa, Bursa, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07664228